✦ LIBER ✦

High-dose cyclophosphamide versus monthly intravenous cyclophosphamide for systemic lupus erythematosus: A prospective randomized trial

✍ Scribed by Michelle Petri; Robert A. Brodsky; Richard J. Jones; Douglas Gladstone; Michael Fillius; Laurence S. Magder

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 77 KB
Volume: 62
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.27371

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunosuppressive therapy in lupus nephr

Immunosuppressive therapy in lupus nephritis: The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide

✍ Frédéric A. Houssiau; Carlos Vasconcelos; David D'Cruz; Gian Domenico Sebastiani 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

Nonrenal disease activity following myco

Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: Findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial

✍ Ellen M. Ginzler; David Wofsy; David Isenberg; Caroline Gordon; Laura Lisk; Mary 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB

Mitoxantrone, 5-fluorouracil, and high d

Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma : A randomized Phase II trial

✍ John D. Hainsworth; Jacques Jolivet; Robert Birch; Lisa G. Hopkins; F. Anthony G 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

Tenfour patients were treated with NFL: mitoxantrone 12 mg/m 2 IV on Day 1; leuconessee. vorin 300 mg IV over 30-60 minutes on Days 1, 2, and 3, immediately preceding